[A case of lupus erythematosus preceded by right heart failure due to pulmonary hypertension]. 1991

N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
Department of Cardiology, Matsuyama Red Cross Hospital.

A 40-year-old woman was admitted because of increasing exertional dyspnea. Right heart failure was suggested by the presence of hepatomegaly, pretibial edema and also echocardiographic findings. Physical examination and echocardiography showed no evidence of valvular disease or congenital heart disease except for right ventricular dilatation and tricuspid regurgitation. The ventricular septum deviated toward the left ventricle throughout the cardiac cycle, but left ventricular function was preserved. Severe pulmonary hypertension averaging 44 mmHg was revealed by cardiac catheterization. Digital subtraction angiography and pulmonary blood flow scintigraphy showed no evidence of pulmonary artery embolism, and no interstitial pulmonary lesions that might have caused pulmonary hypertension were recognized. Hypergammaglobulinemia suggested an autoimmune disorder, and signs of systemic lupus erythematosus (SLE), such as pleural effusion, proteinuria, lymphocytopenia, LE cell phenomenon and antinuclear antibodies were present. Several autoimmune diseases are known to be causative factors of pulmonary hypertension. However, only ten cases of SLE complicated by pulmonary hypertension have been reported the present one. These cases were characterized by a high incidence of Raynaud's phenomenon and positivity for anti-RNP antibody. In our present case, SLE activity was suppressed using prednisolone, but pulmonary hypertension persisted and the patient eventually died due to right cardiac failure. Judging from the clinical course of the ten reported cases of SLE-pulmonary hypertension, there seems to be no hope of improving the pulmonary hypertension once it has become established. Therefore it is important to detect and cure pulmonary hypertension as early as possible.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D014657 Vasculitis Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. Angiitis,Angiitides,Vasculitides

Related Publications

N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
July 2017, Perfusion,
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
March 2023, JACC. Case reports,
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
October 1999, Ryumachi. [Rheumatism],
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
August 2023, European heart journal. Case reports,
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
November 2005, Clinical rheumatology,
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
October 1998, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
July 2015, The European respiratory journal,
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
June 2000, Ryumachi. [Rheumatism],
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
May 2020, Cardiology clinics,
N Matsumoto, and A Yamada, and S Harada, and S Murakami, and S Higuchi, and S Nabeyama, and I Ogata, and T Ashihara, and T Inou, and T Fukuyama
December 1995, Chest,
Copied contents to your clipboard!